PEG-MGF

Not approvedResearch-useChecked 19 Oct 2026

Peptide Chooser editorial team. Every claim links to its source. Prices checked 19 Oct 2026.

Not approved: its nomination for pharmacy compounding was withdrawn. FDA source, 19 Oct 2026.

FDA warning letters

Our letters list is by company, not by substance. The letters page lists all 172, each with its subject and a link to fda.gov; filter it by a company name.

FDA warning letters

Sources

FDA, status of PEG-MGF, 19 Oct 2026: https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks